Alvogen Korea

NCT02814500

Phase 1Status unknown201636 people27 Jun 2016clinicaltrials.gov

NCT02789475

Phase 1Status unknown201638 people3 Jun 2016clinicaltrials.gov

NCT02770261

Phase 3Completed2015219 people12 May 2016clinicaltrials.gov

NCT02730689

Phase 1Completed201466 people6 Apr 2016clinicaltrials.gov

NCT02709187

Phase 1Completed201637 people15 Mar 2016clinicaltrials.gov

NCT02707224

Phase 1Completed201540 people14 Mar 2016clinicaltrials.gov

NCT02445352

Phase 3Completed2014379 people15 May 2015clinicaltrials.gov

NCT02079506

Phase 1Completed201440 people5 Mar 2014clinicaltrials.gov

NCT01581320

Phase 3Completed2011201 people20 Apr 2012clinicaltrials.gov

NCT01577849

Phase 1Completed201236 people16 Apr 2012clinicaltrials.gov